Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research ...

A new, generic, non-steroidal anti-inflammatory drug (NSAID) is now available for managing osteoarthritis (OA) pain in horses ...

Vishal Manchanda highlights the potential challenges the pharmaceutical sector may face in FY27 due to reliance on key drugs ...

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...

Changes are coming to Medicare costs and coverage in 2024. Announced in time for the annual open enrollment period, which ...

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

Secretary Robert F. Kennedy Jr. says he has a “generic list” of people he wants removed from his department. “I have a list ...

Thus far in the calendar year 2025, the Nifty Pharma index has slipped 11 per cent, as against 3.7 per cent fall in Nifty 50.

Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...

The Associated Press In this Sept. 17, 2019 file photo, R. Kelly appears during a hearing at the Leighton Criminal Courthouse in ...